CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Magrath George Chief Executive Officer | Sale | −28,258 | $3.90 | $110K | 2,010,636 |
| 2026-10-23 | Magrath George Chief Executive Officer | Sale | −9,591 | $3.59 | $34K | 2,038,894 |
| 2026-09-09 | Magrath George Chief Executive Officer | Exercise or conversion | +392,157 | $1.15 | $451K | 2,124,026 |
| 2026-09-09 | Magrath George Chief Executive Officer | Shares withheld for taxes | −75,541 | $5.97 | $451K | 2,048,485 |
| 2026-09-09 | Magrath George Chief Executive Officer | Exercise or conversion · Warrant (right to buy) | −392,157 | 0 | ||
| 2026-07-23 | Magrath George Chief Executive Officer | Sale | −9,475 | $2.95 | $28K | 1,731,869 |
| 2026-04-23 | Magrath George Chief Executive Officer | Sale | −9,511 | $5.22 | $50K | 1,741,344 |
| 2026-03-16 | Magrath George Chief Executive Officer | Sale | −24,438 | $5.21 | $127K | 1,750,855 |
| 2026-01-22 | Magrath George Chief Executive Officer | Grant or award | +483,639 | 1,775,293 | ||
| 2025-11-01 | Magrath George Chief Executive Officer | Shares withheld for taxes | −30,350 | $2.30 | $70K | 1,291,654 |
| 2025-11-01 | Magrath George Chief Executive Officer | Shares withheld for taxes | −30,350 | $2.30 | $70K | 1,291,654 |
| 2025-03-24 | Magrath George Chief Executive Officer | Grant or award | +392,157 | 1,322,004 | ||
| 2025-03-24 | Magrath George Chief Executive Officer | Grant or award · Warrants (right to buy) | +392,157 | 392,157 | ||
| 2025-03-13 | Magrath George Chief Executive Officer | Grant or award | +330,697 | 929,847 | ||
| 2025-03-13 | Magrath George Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +330,697 | 330,697 | ||
| 2024-12-26 | Magrath George Chief Executive Officer | Purchase | +100,000 | $0.98 | $98K | 599,150 |
| 2024-12-23 | Magrath George Chief Executive Officer | Grant or award | +6,200 | 499,150 | ||
| 2024-11-18 | Magrath George Chief Executive Officer | Purchase | +9,706 | $1.02 | $10K | 492,950 |
| 2024-11-15 | Magrath George Chief Executive Officer | Purchase | +90,294 | $1.01 | $91K | 483,244 |
| 2024-11-01 | Magrath George Chief Executive Officer | Shares withheld for taxes | −37,050 | $1.18 | $44K | 392,950 |
Page 1 of 2 · 24 trades